Abstract
Introduction The C-31G polymorphism in the survivin promoter could de-represse the cell-cycle-dependent transcription of the human survivin gene, resulting in overexpression of survivin. This survivin mutation has only been studied on cervical carcinoma. However, no study has ever been conducted to evaluate the effect of the polymorphism on other cancers, including gastric cancer. Methods In this hospital-based, case–control study, we investigated the association between the survivin C-31G polymorphism and risk of gastric cancer in a Chinese population using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) protocols. Results No statistically significant association was observed between gastric cancer risk and the variant genotype (GG + GC). However, the variant genotype (GG + GC) was either associated with risk of distal gastric cancer (odds ratios = 0.50, 95% confidence interval = 0.30–0.83) or with risk of well-differentiated tumor (odds ratios = 0.46, 95% confidence interval = 0.22–0.97). Conclusion Our results demonstrate that the survivin C-31G polymorphism may be involved in distal gastric carcinogenesis and tumor differentiation in a Chinese population.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- OR:
-
Odds ratio
- PCR:
-
Polymerase chain reaction
References
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130.
He J, Gu D, Wu X, et al. Major causes of death among men, women in China. N Engl J Med. 2005;353:1124–1134. doi:10.1056/NEJMsa050467.
Wu MS, Chen CJ, Lin JT. Host–environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1878–1882. doi:10.1158/1055-9965.EPI-04-0792.
Roberts-Thomson IC, Butler WJ. Polymorphism and gastric cancer. J Gastroenterol Hepatol. 2005;20:793–794. doi:10.1111/j.1440-1746.2005.03938.x.
Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case–control study. Carcinogenesis. 2006;27:2491–2496. doi:10.1093/carcin/bgl121.
Johnson ME, Howerth EW. Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol. 2004;41:599–607. doi:10.1354/vp.41-6-599.
Li F, Brattain MG. Role of the Survivin gene in pathophysiology. Am J Pathol. 2006;169:1–11. doi:10.2353/ajpath.2006.060121.
Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther. 2006;5:1087–1098. doi:10.1158/1535-7163.MCT-05-0375.
Chiou SK, Moon WS, Jones MK, Tarnawski AS. Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun. 2003;305:374–379. doi:10.1016/S0006-291X(03)00724-1.
Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917–921. doi:10.1038/nm0897-917
Li F. Survivin study: what is the next wave. J Cell Physiol. 2003;197:8–29. doi:10.1002/jcp. 10327.
Ikeguchi M, Kaibara N. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int J Mol Med. 2001;8:661–666.
Rödel F, Hoffmann J, Distel L, et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res. 2005;65:4881–4887. doi:10.1158/0008-5472.CAN-04-3028.
Zhang B, Liu JY, Pan JS, et al. Combined treatment of ionizing radiation with genistein on cervical cancer HeLa cells. J Pharmacol Sci. 2006;102:129–135. doi:10.1254/jphs.FP0060165.
Zhang B, Pan JS, Liu JY, Han SP, Hu G, Wang B. Effects of chemotherapy and/or radiotherapy on survivin expression in ovarian cancer. Methods Find Exp Clin Pharmacol. 2006;28:619–625. doi:10.1358/mf.2006.28.9.1003581.
Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58:1808–1812.
Zhu XD, Lin GJ, Qian LP, Chen ZQ. Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats. World J Gastroenterol. 2003;9:1435–1438.
Yu J, Leung WK, Ebert MP, et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer. 2002;87:91–97. doi:10.1038/sj.bjc.6600421.
Wang ZN, Xu HM, Jiang L, Zhou X, Lu C, Zhang X. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World J Gastroenterol. 2004;10:3094–3098.
Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by surviving. Nature. 1998;396:580–584. doi:10.1038/25141.
Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T. Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta. 2000;1493:188–194.
Li F, Altieri DC. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 1999;59:3143–3151.
Xu Y, Fang F, Ludewig G, Jones G, Jones D. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004;23:419–429. doi:10.1089/1044549041474788.
Borbély AA, Murvai M, Szarka K, et al. Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol. 2007;60:303–306. doi:10.1136/jcp. 2006.037804.
Reed JC. The Survivin saga goes in vivo. J Clin Invest. 2001;108:965–969. doi:10.1172/JCI14123.
Miyachi K, Sasaki K, Onodera S, et al. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer. 2003;6:217–224. doi:10.1007/s10120-003-0255-2.
Kania J, Konturek SJ, Marlicz K, Hahn EG, Konturek PC. Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci. 2003;48:266–271. doi:10.1023/A:1021915124064.
Tu SP, Jiang XH, Lin MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 2003;63:7724–7732.
Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski AS. Survivin: a novel target for indomethacin-induced gastric injury. Gastroenterology. 2005;128:63–73. doi:10.1053/j.gastro.2004.10.008.
Meng H, Lu C, Mabuchi H, Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett. 2004;216:147–155. doi:10.1016/j.canlet.2003.12.020.
Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF-kappaB, survivin, Bcl–2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol. 2004;10:22–25.
Ikeguchi M, Liu J, Kaibara N. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis. 2002;7:23–29. doi:10.1023/A:1013556727182.
Nakamura M, Tsuji N, Asanuma K, et al. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients. Cancer Sci. 2004;95:44–51. doi:10.1111/j.1349-7006.2004.tb03169.x.
Wakana Y, Kasuya K, Katayanagi S, et al. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep. 2002;9:1213–1218.
Koyama S. Differential expression of intracellular apoptotic signaling molecules in tumor and tumor-infiltrating lymphocytes during development of invasion and/or metastasis of gastric carcinoma. Dig Dis Sci. 2003;48:2290–2300. doi:10.1023/B:DDAS.0000007865.96569.9a.
Acknowledgments
This project was supported by grants from the National Natural Science Foundation of China (No. 30672486), and the Natural Science Foundation of Jiangsu Province (No. BK2006525), “333 Project”, “Qinglan Project,” and “Six RenCai Gaofeng (No. 07C008)” Funding for the Young Academic Leader of Jiangsu Province to Dr. Bin Wang.
Author information
Authors and Affiliations
Corresponding author
Additional information
Drs. L. Yang, H. Zhu, B. Zhou, and H. Gu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yang, L., Zhu, H., Zhou, B. et al. The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population. Dig Dis Sci 54, 1021–1028 (2009). https://doi.org/10.1007/s10620-008-0441-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0441-5